The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine

  title={The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-$\beta$42 with memantine},
  author={Csaba Nyakas and Iviça Granic and L{\'a}szl{\'o} G. Halmy and Pradeep K. Banerjee and Paul G. M. Luiten},
  journal={Behavioural Brain Research},

Figures from this paper

The Cholinergic System, the Adrenergic System and the Neuropathology of Alzheimer’s Disease

  • R. Bekdash
  • Biology, Psychology
    International journal of molecular sciences
  • 2021
The aim of this review is to describe current literature on the role of the cholinergic system and the adrenergic system (LC-NE) in the pathology of Alzheimer's disease and potential therapeutic implications.

Amyloid-β, tau, and the cholinergic system in Alzheimer’s disease: seeking direction in a tangle of clues

None of the popular hypotheses of AD such as amyloidopathy or tauopathy seem to be responsible for the changes observed in AD alone, so the main culprit should be sought higher in the stream somewhere in APP metabolism or Wnt signaling in the cholinergic system of the basal forebrain.

Cholinergic signalling in the forebrain controls microglial phenotype and responses to systemic inflammation

The data indicate that neurodegeneration-evoked loss of cholinergic tone, triggers microglial activation via impairedmicroglial nicotinic signalling and leaves these microglia more vulnerable to secondary inflammatory insults.

Neuroprotection of medial septal cholinergic neurons by memantine after intralateral septal injection of A&bgr;1–40

Rats injected with A&bgr;1–40 into the lateral septal region structure with rats treated with memantine have a significantly low number of medial septum and diagonal band of Broca cholinergic neurons compared with the A& bgr;/memantine-treated group.

The Organic Cation Transporter 2 Inhibitor Quinidine Modulates the Neuroprotective Effect of Nerve Growth Factor and Memantine on Cholinergic Neurons of the Basal Nucleus of Meynert in Organotypic Brain Slices

Evidence is provided that quinidine modulates the survival of cholinergic nBM neurons via OCT2 through inhibition of organic cation transporter 2 and the protective effect of NGF and memantine when applied simultaneously.

Alzheimer's disease, β‐amyloid, glutamate, NMDA receptors and memantine – searching for the connections

Strong support for the clinical relevance of such interactions is provided by the NMDA receptor antagonist memantine, which offers an excellent tool to facilitate translational extrapolations from in vitro studies through in vivo animal experiments to its ultimate clinical utility.

Nicotinic Acetylcholine Receptor Agonists for the Treatment of Alzheimer's Dementia: An Update.

A significant portion of the clinical phenotype observed in Alzheimer's disease (AD) occurs through nicotinic acetylcholine receptors (nAChRs), and agonists of these receptors will likely exert pro-cognitive benefits through multiple mechanisms including stimulating the cholinergic pathway, modulating inflammation, and buffering the effects of amyloid.

Cholinergic Differentiation of Human Neuroblastoma SH-SY5Y Cell Line and Its Potential Use as an In vitro Model for Alzheimer’s Disease Studies

Challenging RA + BDNF-differentiated SH-SY5Y cells with the combination of sublethal doses of OA and AβO, without causing considerable decrease of cell viability, provides an in vitro model which mimics the early-stage pathophysiology of cholinergic neurons affected by AD.

The Neurotrophins and Their Role in Alzheimer’s Disease

The pathology, symptoms and molecular processes associated with Alzheimer’s disease are described and the involvement of the neurotrophins, particularly NGF and BDNF, and their receptors, are discussed, with changes in BDNF considered particularly in the light of its importance in synaptic plasticity.



Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies.

This review will initially discuss recent results indicating a link between cholinergic mechanisms and the pathogenic events that characterize AD, notably amyloid-beta peptides, and animal models of dementia will be discussed in light of the relationship between basal forebrain cholinerg hypofunction and cognitive impairments in AD.

The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease

Understanding the molecular mechanisms underlying the interrelationship between cortical cholinergic dysfunction, β-amyloid formation and deposition, and tau pathology in Alzheimer’s disease, would allow to derive potential treatment strategies to pharmacologically intervene in the disease-causing signaling cascade.

beta-Amyloid excitotoxicity in rat magnocellular nucleus basalis. Effect of cortical deafferentation on cerebral blood flow regulation and implications for Alzheimer's disease.

In the present account, coherent in vivo experimental evidence is reviewed that A beta infusion into the rat magnocellular nucleus basalis induces abrupt and persistent behavioral dysfunctions, perturbations of sensory information processing, storage, and retrieval that may directly enhance neuronal vulnerability during aging and in Alzheimer's disease.

Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction

Synaptic degeneration in Alzheimer’s disease

The hypothesis that differentiated neurons after having withdrawn from the cell cycle are able to use molecular mechanisms primarily developed to control proliferation alternatively to control synaptic plasticity is formulated and a role for diffusible oligomers of amyloid β in synaptic dysfunction is suggested.

Cholinergically mediated augmentation of cerebral perfusion in Alzheimer's disease and related cognitive disorders: the cholinergic-vascular hypothesis.

  • J. ClaassenR. Jansen
  • Psychology, Biology
    The journals of gerontology. Series A, Biological sciences and medical sciences
  • 2006
It is proposed that the role of the cholinergic system in neurovascular regulation and functional hyperemia elucidates how thecholinergic deficit in AD contributes to the clinical and pathological features of this disease.

Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease

The results demonstrate a loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease but no marked reduction in postencephalitic parkinsonism, Huntington's disease, chronic alcoholism without dementia, schizophrenia and infantile brain damage.